医麦客新闻 eMedClub News
近日,REGENXBIO宣布成功完成了RGX-121治疗黏多糖贮积症II型(MPS II)的生物制剂许可申请前(BLA)会议,并与美国FDA敲定了BLA的细节。
FDA继续同意REGENXBIO的计划,使用脑脊液(CSF)硫酸乙酰肝素D2S6水平(脑部疾病活动的关键生物标志...查看全文
Regenxbio(RGNX)06-05 04:45
$Regenxbio(RGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-24-004653 Size: 7 KB 网页链接查看全文
Regenxbio(RGNX)05-15 04:25
$Regenxbio(RGNX)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-003648 Act: 33 Size: 6 KB 网页链接查看全文
Regenxbio(RGNX)06-04 04:45
$Regenxbio(RGNX)$ 8-K Current report, items 5.07 and 9.01 Accession Number: 0000950170-24-068050 Act: 34 Size: 162 KB 网页链接查看全文
Regenxbio(RGNX)06-05 04:45
$Regenxbio(RGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-24-004656 Size: 7 KB 网页链接查看全文
Regenxbio(RGNX)06-05 04:45
$Regenxbio(RGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-24-004654 Size: 7 KB 网页链接查看全文
Regenxbio(RGNX)07-03 20:05
$Regenxbio(RGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-24-005566 Size: 9 KB 网页链接查看全文
Regenxbio(RGNX)07-19 05:15
$Regenxbio(RGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-24-005798 Size: 14 KB 网页链接查看全文
Regenxbio(RGNX)05-17 05:15
$Regenxbio(RGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-24-004104 Size: 9 KB 网页链接查看全文
Regenxbio(RGNX)06-05 04:45
$Regenxbio(RGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-24-004652 Size: 7 KB 网页链接查看全文
Replix锐璞美股2020-05-31 22:48
除了基因编辑三剑客CRSP/EDIT/NTLA,基因治疗我们还覆盖了$uniQure(QURE)$ 网页链接
Regenxbio(RGNX)$ 网页链接
Abeona Therapeutics(ABEO)${Abeona Therapeutics(ABEO)$} 网页链接查看全文
富兰克30美股指数2020-03-03 09:46
今天美国总统川普在白宫会见的医药公司名单
$Inovio制药(INO)$
$Moderna(MRNA)$ $Regenxbio(RGNX)$
NVAX 不知道是否在其中,有知道详细名单的请补充。查看全文
chuminhua2019-11-20 14:33
11/11,Regenxbio$Regenxbio(RGNX)$ 正在将FDA告上法庭,诉讼称,FDA“未做任何通知或解释”就给予其临床停,并在伺候拒绝了该公司一再要求对该行动进行解释的要求。该公司要求法院发出永久性禁令,以恢复其受到影响的全部临床试验。上个月,FDA通知该公司2个IND被全部暂停,立即生效,且未提供原...查看全文
chuminhua2019-11-16 15:24
11/7,在2019Q3季报中,RegenxBio$Regenxbio(RGNX)$ 称其基因疗法RGX-314的临床被FDA部分暂停,该机构正在审查其使用的递送药物的某些第三方商业化的设备。因此,该公司无法按计划开始湿性AMD的IIb期研究,并要到2020年初才能提交基于II期糖尿病性视网膜病研究的IND。查看全文
Zuluzulu2019-11-06 21:37
RGNX FDA partial clinical hold on RGX-314 wet-AMD study due to FDA concerns on third-party surgical devices used for subretinal delivery $Regenxbio(RGNX)$查看全文
$Regenxbio(RGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-24-005798 Size: 14 KB 网页链接
$Regenxbio(RGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-24-005566 Size: 9 KB 网页链接
$Regenxbio(RGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-24-005567 Size: 8 KB 网页链接
$Regenxbio(RGNX)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-005142 Act: 33 Size: 5 KB 网页链接
$Regenxbio(RGNX)$ 8-K Current report, items 5.02, 7.01, and 9.01 Accession Number: 0001193125-24-160146 Act: 34 Size: 179 KB 网页链接
$Regenxbio(RGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-24-004649 Size: 7 KB 网页链接
$Regenxbio(RGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-24-004650 Size: 7 KB 网页链接
$Regenxbio(RGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-24-004651 Size: 10 KB 网页链接
$Regenxbio(RGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-24-004652 Size: 7 KB 网页链接
$Regenxbio(RGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-24-004653 Size: 7 KB 网页链接